Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study

Completed · Phase 3

Conditions studied: Asthma

In brief

The purpose of this study is to evaluate the long-term safety of fluticasone furoate/GW642444

Key facts

Study ID

NCT01018186

Run by

GlaxoSmithKline

People needed

503

Starts

2009-10-19

Expected to finish

2011-05-12

Last updated by the study team

2018-02-15

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of asthma
• Reversibility FEV1 of twelve percent or greater and two hundred milliliters and greater approximately ten to forty minutes following two to four inhalations of albuterol
• FEV1 greater than or equal to fifty percent of predicted
• Currently using moderate to high dose inhaled corticosteroid therapy

You may not qualify if…

• History of life threatening asthma
• Respiratory infection or oral candidiasis
• Asthma exacerbation
• Uncontrolled disease or clinical abnormality
• Allergies
• Taking another investigational medication or prohibited medication

Where it is running

• GSK Investigational Site — Oxford, Alabama, United States
• GSK Investigational Site — Huntington Beach, California, United States
• GSK Investigational Site — Mission Viejo, California, United States
• GSK Investigational Site — Rolling Hills Estates, California, United States
• GSK Investigational Site — Stockton, California, United States
• GSK Investigational Site — Bethesda, Maryland, United States
• GSK Investigational Site — Bellevue, Nebraska, United States
• GSK Investigational Site — Skillman, New Jersey, United States
• GSK Investigational Site — Raleigh, North Carolina, United States
• GSK Investigational Site — Cincinnati, Ohio, United States
• GSK Investigational Site — Oklahoma City, Oklahoma, United States
• GSK Investigational Site — Austin, Texas, United States
• GSK Investigational Site — Dallas, Texas, United States
• GSK Investigational Site — El Paso, Texas, United States
• GSK Investigational Site — San Antonio, Texas, United States
• GSK Investigational Site — Waco, Texas, United States
• GSK Investigational Site — South Burlington, Vermont, United States
• GSK Investigational Site — Greenfield, Wisconsin, United States
• GSK Investigational Site — Mannheim, Baden-Wurttemberg, Germany
• GSK Investigational Site — Bad Woerrishofen, Bavaria, Germany
• GSK Investigational Site — Potsdam, Brandenburg, Germany
• GSK Investigational Site — Donetsk, Ukraine
• GSK Investigational Site — Kyiv, Ukraine
• GSK Investigational Site — Kyiv, Ukraine
• GSK Investigational Site — Kyiv, Ukraine

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.